agreement

EISAI AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST.  LOUIS SIGNED GLOBAL RESEARCH COLLABORATION AGREEMENT TO CREATE NEW THERAPIES FOR NEURODEGENERATIVE DISEASES

EISAI AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS SIGNED GLOBAL RESEARCH COLLABORATION AGREEMENT TO CREATE NEW THERAPIES FOR NEURODEGENERATIVE DISEASES

TOKYO, December 14, 2022 /PRNewswire/ — Eisai Co., Ltd. (headquarters : TokyoCEO: Haruo Naito“Eisai”) announced today that Eisai and University of Washington School of Medicine Saint Louis have entered into a global research collaboration agreement aimed at creating potential new treatments for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). University of Washington …

EISAI AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS SIGNED GLOBAL RESEARCH COLLABORATION AGREEMENT TO CREATE NEW THERAPIES FOR NEURODEGENERATIVE DISEASES Read More »

TopGum signs a 5-year agreement to develop gummy supplements for a major international company

TopGum signs a 5-year agreement to develop gummy supplements for a major international company

TopGum Industries, an Israeli maker of dietary supplements and gum candies, announced on Sunday that it has signed a five-year deal to develop nutritional supplements for a major multinational. TopGum described the unnamed entity as a “large international company worth more than $150 billion that produces and markets its products in approximately 200 countries around …

TopGum signs a 5-year agreement to develop gummy supplements for a major international company Read More »

Intrinsic Medicine and Phoenix Biotech Acquisition Corp.  mutually agree to terminate the business combination agreement

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. mutually agree to terminate the business combination agreement

SEATTLE, 06 Dec. 12, 2022 (GLOBE NEWSWIRE) — Intrinsic Medicine, Inc. (Intrinsic), a therapeutic company leveraging breast milk biology to transform gut-brain axis (GBA) and inflammatory disorders, and Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (PBAX), a special purpose acquisition company sponsored by Phoenix Biotech Sponsor, LLC and formed for the purpose of acquiring or merging with …

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. mutually agree to terminate the business combination agreement Read More »